The Antleron team is present at the EIT Health Summit in Paris. We are exploring the innovative talks, projects and stakeholders which are pushing the boundaries of healthcare. Tomorrow, Antleron will showcase at Stand 41 in the start-up village. Always welcome to visit and attend.
Antleron's showcase focuses on BioScout, the custom screening of biomaterials and medical devices. Typically, it entails a closed, 4D in-vitro platform for longitudinal and quality-focused functionality screening. The fast track from lab to patient optimizes your resource use, prioitizes your leads, and de-risks your R&D pipeline.
Antleron's showcase focuses on BioScout, the custom screening of biomaterials and medical devices. Typically, it entails a closed, 4D in-vitro platform for longitudinal and quality-focused functionality screening. The fast track from lab to patient optimizes your resource use, prioitizes your leads, and de-risks your R&D pipeline.
BioScout is a 'technology as a service' which came to life by merging technologies including 3D printing, a modular bioreactor backbone, 3D cell culture and non-invasive, machine learning based monitoring. These technologies in a quality-by-design framework forms the basis for BioScout.
Antleron's multi-disciplinary approach will make BioScout a unique service on the market for biomaterial and medical device manufacturers, ATMP development companies and academic institutions.
